SFRP1 and breast carcinoma: Previous studies have shown that SFRP1 can be used as a prognostic marker in breast cancer [36–38] and SFRP1 might be used as a marker for chemotherapy and neoadjuvant chemotherapy response in triple-negative breast cancer [39, 40].